Condition: Psoriasis · Sponsor: Psoriasis Treatment Center of Central New Jersey
Patient with moderate-to-severe plaque psoriasis will receive Ilumya with or without Halog ointment.
This description comes directly from the study's public registry record.
Jerry Bagel, MD · 6094434500 · dreamacres1@aol.com
Elise Nelson · 6094434500 · enelson@windsordermatology.com
Always discuss trial participation with your own doctor first.
| Psoriasis Treatment Center of Central New Jersey | East Windsor, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04347473